Funding · Company
Graviton BioScience Corp
New York, NYBiotech & Pharma
Graviton BioScience Corp of New York, NY has disclosed $90M across 3 Form D offerings filed with the SEC between Dec 4, 2023 and Feb 14, 2024.
$90M
Total disclosed
3
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$40M
Form D · Dec 4, 2023 ↗
Q4 2023
· target $50M
Filing details
HeadquartersNew York, NYIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0001847048Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →